APC |
Antigen-presenting cell |
BM |
Bone marrow |
BMT |
Bone marrow transplantation |
BST2 |
Bone marrow stromal antigen 2 |
CBT |
Cord blood transplantation |
cDCs |
Conventional DCs |
CLR |
C-type lectin-like receptors |
CRPC |
Castration-resistant prostate cancer |
CTLs |
CD8+ cytotoxic T lymphocytes |
CXCL |
C-X-C motif chemokine ligands |
CXCR3 |
C-X-C motif chemokine receptor 3 |
DCs |
Dendritic cells |
Flt3L |
Fms-like tyrosine kinase 3-ligand |
GM-CSF |
Granulocyte-macrophage colony stimulating factor |
HNSCC |
Head and neck squamous cell carcinomas |
HSPCs |
Hematopoietic stem and progenitor cells |
IDO |
Immunoregulatory enzyme indoleamine 2,3-dioxygenase |
IFN-I |
Type I Interferon |
IFNR |
IFN receptor |
IL-3 |
Interleukin 3 |
ILT7 |
Immunoglobulin-like cell transcript 7 |
IMQ |
Imiquimod |
IRF |
Interferon Regulatory Factor |
MHC |
Major histocompatibility complex |
moDCs |
Monocyte-derived dendritic cells |
NK |
Natural killer |
OS |
Overall survival |
PBMCs |
Peripheral blood mononuclear cells |
pDCs |
Plasmacytoid DCs |
PFS |
Progression-free survival |
PGE2 |
Prostaglandin E2 |
SLN |
Sentinel lymph node |
TAA |
Tumor-associated antigens |
TGF-β |
Transforming growth factor- β |
TILs |
Tumor-infiltrating lymphocytes |
TLR |
Toll-like receptors |
TME |
Tumor microenvironment |
TNF |
Tumor necrosis factor |
TRAIL-R2 |
TRAIL receptor-2 |
Treg |
Regulatory T cells |